Balaxi Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹33.57
-3.73-10.00% (1D)
As on 20 Nov 2026 at 15:59
As of 20 Nov 2026 at 15:59, Balaxi Pharmaceuticals Ltd is trading at ₹33.57. The 52-week range stands at ₹15.20–₹40.98, with a market cap of ₹185.33 crore. At a P/E of 335.70 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

BALAXI Price Chart

Market Cap
₹185.33 Cr
PE Ratio
335.70
ROCE
2.55%

Balaxi Pharmaceuticals Ltd Performance

Balaxi Pharmaceuticals Ltd Fundamentals

Know More
Market Cap₹185.33 Cr
ROE0.41%
P/E Ratio (TTM)335.70
EPS (TTM)₹0.10
P/B Ratio1.41
Dividend Yield0.00%
Industry P/E91.72
Book Value₹23.88
Debt to Equity0.23
Face Value₹2

Balaxi Pharmaceuticals Ltd Shareholding Pattern

Know More
Promoter66%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions2.6%
Public31.4%

Balaxi Pharmaceuticals Ltd Financial Statements

Know More
No data for this view.

Balaxi Pharmaceuticals Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Balaxi Pharmaceuticals

Balaxi Pharmaceuticals Limited was initially incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942. The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017 and further changed to Balaxi Pharmaceuticals Limited in 2021. Initially, the Company was incorporated with the object of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.e. Mr. Nirej V. Paul, Mr. V. M. Paulose, Dr. Leelamma T. J and Mrs. Jaya Paul) to acquire 1,670,036 Equity Shares representing 54.94% of the paid up share capital of the Company along with the control over the Company, pursuant to which BOPL made an Open Offer under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011. Control and management of the Company was acquired by BOPL on May 04, 2017 and it became the new promoter of Company and their representatives i.e. Mr. Ashish Maheshwari and Mrs. Minoshi Maheshwari became the new Directors of the Company. Simultaneously, erstwhile promoters stepped down as promoters from Company on same day and Mr. Nirej V. Paul and Dr. Leelamma TJ resigned as Managing Director and as Chairperson from the Company, respectively. Under the above said Open Offer, BOPL acquired 3,30,000 equity shares representing 10.86% equity share capital of the Company. On completion of the Open Offer BOPL became the holding and Promoter Company with an aggregate shareholding of 2000036 Equity Shares (ie 65.79%). The main objects of the company were amended to include activities of International wholesale trading in pharmaceutical, food products and builders' hardware on August 08, 2018. The Company commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG products from Financial Year 2018-19. Further, in February 2019, it kickstarted Food Products business by launching a range of biscuits under the brand YAP'. The Company expanded its presence by establishing a central distribution warehouse in Guatemala. This expansion helped in strengthening the network and a wider customer base in 2019. In FY 2024, Company started operations in two Latin American Countries, i.e., Honduras and El Salvador and also started operations in the Central African Republic. The Company completed its first formulation facility in Jadcherla, Hyderabad, focused on General Oral Solid Dosage (OSD) forms in 2025.

Parent Organisation—
Founded1942
Managing DirectorAshish Maheshwari
NSE SymbolBALAXI

Balaxi Pharmaceuticals Ltd Resistance and Support levels

R341.87R239.51R138.05S133.33S231.87S329.5133.57

Balaxi Pharmaceuticals Ltd Technicals

Current Price
₹33.57 ₹3.73 (-10.00%)
Bearish
0
Bullish
12
  • 20 Day36.7%
  • 50 Day44.2%
  • 100 Day43.0%
  • 200 Day28.6%

Balaxi Pharmaceuticals Ltd Latest News

View More
27 JUL 2026 | Monday
Balaxi Pharmaceuticals to announce Quarterly Result
01 JUN 2026 | Monday
Balaxi Pharmaceuticals to conduct AGM

2026

Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Board MeetingAnnounced
Board MeetingAnnounced

Frequently asked questions

The share price of Balaxi Pharmaceuticals Ltd is ₹33.57 as of 20 Nov 2026 at 15:59.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now